Compile Data Set for Download or QSAR
Found 4903 with Last Name = 'gerstenberger' and Initial = 'bs'
TargetTyrosine-protein kinase BTK(Homo sapiens (Human))
Pfizer Inc

Curated by ChEMBL
LigandPNGBDBM50399459(CHEMBL2179805)
Show SMILES CC(C)c1ccc(NC(=O)c2cccc(c2)-c2nn([C@@H]3CCCN(C3)C(=O)C=C)c3ncnc(N)c23)cc1C
Show InChI InChI=1S/C30H33N7O2/c1-5-25(38)36-13-7-10-23(16-36)37-29-26(28(31)32-17-33-29)27(35-37)20-8-6-9-21(15-20)30(39)34-22-11-12-24(18(2)3)19(4)14-22/h5-6,8-9,11-12,14-15,17-18,23H,1,7,10,13,16H2,2-4H3,(H,34,39)(H2,31,32,33)/t23-/m1/s1
Affinity DataIC50: 2nMAssay Description:Inhibition of BTK in presence of 50 uM ATPMore data for this Ligand-Target Pair
TargetTyrosine-protein kinase ITK/TSK(Homo sapiens (Human))
Pfizer Inc

Curated by ChEMBL
LigandPNGBDBM50399459(CHEMBL2179805)
Show SMILES CC(C)c1ccc(NC(=O)c2cccc(c2)-c2nn([C@@H]3CCCN(C3)C(=O)C=C)c3ncnc(N)c23)cc1C
Show InChI InChI=1S/C30H33N7O2/c1-5-25(38)36-13-7-10-23(16-36)37-29-26(28(31)32-17-33-29)27(35-37)20-8-6-9-21(15-20)30(39)34-22-11-12-24(18(2)3)19(4)14-22/h5-6,8-9,11-12,14-15,17-18,23H,1,7,10,13,16H2,2-4H3,(H,34,39)(H2,31,32,33)/t23-/m1/s1
Affinity DataIC50: 2nMAssay Description:Covalent inhibition of ITK in presence of 1 mM ATPMore data for this Ligand-Target Pair
TargetTyrosine-protein kinase ITK/TSK(Homo sapiens (Human))
Pfizer Inc

Curated by ChEMBL
LigandPNGBDBM50399459(CHEMBL2179805)
Show SMILES CC(C)c1ccc(NC(=O)c2cccc(c2)-c2nn([C@@H]3CCCN(C3)C(=O)C=C)c3ncnc(N)c23)cc1C
Show InChI InChI=1S/C30H33N7O2/c1-5-25(38)36-13-7-10-23(16-36)37-29-26(28(31)32-17-33-29)27(35-37)20-8-6-9-21(15-20)30(39)34-22-11-12-24(18(2)3)19(4)14-22/h5-6,8-9,11-12,14-15,17-18,23H,1,7,10,13,16H2,2-4H3,(H,34,39)(H2,31,32,33)/t23-/m1/s1
Affinity DataIC50: 2nMAssay Description:Covalent inhibition of ITK in presence of 5 uM ATPMore data for this Ligand-Target Pair
TargetNon-receptor tyrosine-protein kinase TYK2(Homo sapiens (Human))
Pfizer Inc.

US Patent
LigandPNGBDBM329926(US10463675, Example 9 | US10980815, Ex. No. 9 | US...)
Show SMILES CCNC(=O)c1ccc(Nc2ncc(F)c(n2)N2C[C@@H]3CC[C@H](C2)N3C(=O)C2CC2)cc1
Show InChI InChI=1S/C23H27FN6O2/c1-2-25-21(31)14-5-7-16(8-6-14)27-23-26-11-19(24)20(28-23)29-12-17-9-10-18(13-29)30(17)22(32)15-3-4-15/h5-8,11,15,17-18H,2-4,9-10,12-13H2,1H3,(H,25,31)(H,26,27,28)/t17-,18+
Affinity DataIC50: 4nMAssay Description:Compounds were added to a 384-well plate. Reaction mixtures contained 10 mM HEPES, pH 7.4, 10 mM MgCl2, 0.01% BSA, 0.0005% Tween 20, 1 mM ATP and 1 M...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
TargetNon-receptor tyrosine-protein kinase TYK2(Homo sapiens (Human))
Pfizer Inc.

US Patent
LigandPNGBDBM329926(US10463675, Example 9 | US10980815, Ex. No. 9 | US...)
Show SMILES CCNC(=O)c1ccc(Nc2ncc(F)c(n2)N2C[C@@H]3CC[C@H](C2)N3C(=O)C2CC2)cc1
Show InChI InChI=1S/C23H27FN6O2/c1-2-25-21(31)14-5-7-16(8-6-14)27-23-26-11-19(24)20(28-23)29-12-17-9-10-18(13-29)30(17)22(32)15-3-4-15/h5-8,11,15,17-18H,2-4,9-10,12-13H2,1H3,(H,25,31)(H,26,27,28)/t17-,18+
Affinity DataIC50: 4nMAssay Description:Compounds were added to a 384-well plate. Reaction mixtures contained 10 mM HEPES, pH 7.4, 10 mM MgCl2, 0.01% BSA, 0.0005% Tween 20, 1 mM ATP and 1 &...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
TargetNon-receptor tyrosine-protein kinase TYK2(Homo sapiens (Human))
Pfizer Inc.

US Patent
LigandPNGBDBM329926(US10463675, Example 9 | US10980815, Ex. No. 9 | US...)
Show SMILES CCNC(=O)c1ccc(Nc2ncc(F)c(n2)N2C[C@@H]3CC[C@H](C2)N3C(=O)C2CC2)cc1
Show InChI InChI=1S/C23H27FN6O2/c1-2-25-21(31)14-5-7-16(8-6-14)27-23-26-11-19(24)20(28-23)29-12-17-9-10-18(13-29)30(17)22(32)15-3-4-15/h5-8,11,15,17-18H,2-4,9-10,12-13H2,1H3,(H,25,31)(H,26,27,28)/t17-,18+
Affinity DataIC50: 4nMAssay Description:Compounds were added to a 384-well plate. Reaction mixtures contained 10 mM HEPES, pH 7.4, 10 mM MgCl2, 0.01% BSA, 0.0005% Tween 20, 1 mM ATP and 1 &...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
TargetNon-receptor tyrosine-protein kinase TYK2(Homo sapiens (Human))
Pfizer Inc.

US Patent
LigandPNGBDBM329926(US10463675, Example 9 | US10980815, Ex. No. 9 | US...)
Show SMILES CCNC(=O)c1ccc(Nc2ncc(F)c(n2)N2C[C@@H]3CC[C@H](C2)N3C(=O)C2CC2)cc1
Show InChI InChI=1S/C23H27FN6O2/c1-2-25-21(31)14-5-7-16(8-6-14)27-23-26-11-19(24)20(28-23)29-12-17-9-10-18(13-29)30(17)22(32)15-3-4-15/h5-8,11,15,17-18H,2-4,9-10,12-13H2,1H3,(H,25,31)(H,26,27,28)/t17-,18+
Affinity DataIC50: 4nMAssay Description:Compounds were added to a 384-well plate. Reaction mixtures contained 10 mM HEPES, pH 7.4, 10 mM MgCl2, 0.01% BSA, 0.0005% Tween 20, 1 mM ATP and 1 &...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
TargetNon-receptor tyrosine-protein kinase TYK2(Homo sapiens (Human))
Pfizer Inc.

US Patent
LigandPNGBDBM538959(US11254668, Example 302 | US11254668, Example 303)
Show SMILES N#CCC1(CC(C1)C#N)n1ncc(n1)-c1cc(cc2ncccc12)-c1cc[nH]n1
Show InChI InChI=1S/C21H16N8/c22-5-4-21(10-14(11-21)12-23)29-26-13-20(28-29)17-8-15(18-3-7-25-27-18)9-19-16(17)2-1-6-24-19/h1-3,6-9,13-14H,4,10-11H2,(H,25,27)
Affinity DataIC50: 5nMAssay Description:Compounds were added to a 384-well plate. Reaction mixtures contained 10 mM HEPES, pH 7.4, 10 mM MgCl2, 0.01% BSA, 0.0005% Tween 20, 1 mM ATP and 1 &...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
TargetTyrosine-protein kinase BTK(Homo sapiens (Human))
Pfizer Inc

Curated by ChEMBL
LigandPNGBDBM50399460(CHEMBL2179804)
Show SMILES CC(C)c1ccc(NC(=O)c2cccc(c2)-c2nn([C@@H]3CCCN(C3)C(=O)C=C)c3ncnc(N)c23)cc1
Show InChI InChI=1S/C29H31N7O2/c1-4-24(37)35-14-6-9-23(16-35)36-28-25(27(30)31-17-32-28)26(34-36)20-7-5-8-21(15-20)29(38)33-22-12-10-19(11-13-22)18(2)3/h4-5,7-8,10-13,15,17-18,23H,1,6,9,14,16H2,2-3H3,(H,33,38)(H2,30,31,32)/t23-/m1/s1
Affinity DataIC50: 5nMAssay Description:Inhibition of BTK in presence of 50 uM ATPMore data for this Ligand-Target Pair
TargetNon-receptor tyrosine-protein kinase TYK2(Homo sapiens (Human))
Pfizer Inc.

US Patent
LigandPNGBDBM538756(US11254668, Example 97 | US11254668, Example 98)
Show SMILES Nc1n[nH]cc1-c1cc2ncccc2c(n1)-c1ccn(n1)C1(CC#N)CC(C1)C#N
Show InChI InChI=1S/C21H17N9/c22-5-4-21(9-13(10-21)11-23)30-7-3-16(29-30)19-14-2-1-6-25-17(14)8-18(27-19)15-12-26-28-20(15)24/h1-3,6-8,12-13H,4,9-10H2,(H3,24,26,28)
Affinity DataIC50: 5nMAssay Description:Compounds were added to a 384-well plate. Reaction mixtures contained 10 mM HEPES, pH 7.4, 10 mM MgCl2, 0.01% BSA, 0.0005% Tween 20, 1 mM ATP and 1 &...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
TargetNon-receptor tyrosine-protein kinase TYK2(Homo sapiens (Human))
Pfizer Inc.

US Patent
LigandPNGBDBM538976(US11254668, Example 319 | US11254668, Example 320)
Show SMILES Nc1[nH]ncc1-c1cc(-c2cnn(n2)C2(CC#N)CC(C2)C#N)c2cccnc2c1
Show InChI InChI=1S/C21H17N9/c22-4-3-21(8-13(9-21)10-23)30-27-12-19(29-30)16-6-14(17-11-26-28-20(17)24)7-18-15(16)2-1-5-25-18/h1-2,5-7,11-13H,3,8-9H2,(H3,24,26,28)
Affinity DataIC50: 5nMAssay Description:Compounds were added to a 384-well plate. Reaction mixtures contained 10 mM HEPES, pH 7.4, 10 mM MgCl2, 0.01% BSA, 0.0005% Tween 20, 1 mM ATP and 1 &...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
TargetNon-receptor tyrosine-protein kinase TYK2(Homo sapiens (Human))
Pfizer Inc.

US Patent
LigandPNGBDBM305820((1s,3s)-3-(Cyanomethyl)-3-(4-(6-(1-methyl-1H-pyraz...)
Show SMILES Cn1cc(cn1)-c1cn2nccc2c(n1)-c1cnn(c1)[C@]1(CC#N)C[C@@H](C1)C#N
Show InChI InChI=1S/C20H17N9/c1-27-11-15(9-24-27)17-13-28-18(2-5-23-28)19(26-17)16-10-25-29(12-16)20(3-4-21)6-14(7-20)8-22/h2,5,9-14H,3,6-7H2,1H3/t14-,20+
Affinity DataIC50: 6nMAssay Description:Compounds were added to a 384-well plate. Reaction mixtures contained 10 mM HEPES, pH 7.4, 10 mM MgCl2, 0.01% BSA, 0.0005% Tween 20, 1 mM ATP and 1 &...More data for this Ligand-Target Pair
TargetTyrosine-protein kinase JAK2(Homo sapiens (Human))
Pfizer Inc.

US Patent
LigandPNGBDBM538756(US11254668, Example 97 | US11254668, Example 98)
Show SMILES Nc1n[nH]cc1-c1cc2ncccc2c(n1)-c1ccn(n1)C1(CC#N)CC(C1)C#N
Show InChI InChI=1S/C21H17N9/c22-5-4-21(9-13(10-21)11-23)30-7-3-16(29-30)19-14-2-1-6-25-17(14)8-18(27-19)15-12-26-28-20(15)24/h1-3,6-8,12-13H,4,9-10H2,(H3,24,26,28)
Affinity DataIC50: 6nMAssay Description:Compounds were added to a 384-well plate. Reaction mixtures contained 10 mM HEPES, pH 7.4, 10 mM MgCl2, 0.01% BSA, 0.0005% Tween 20, 1 mM ATP and 1 &...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
TargetNon-receptor tyrosine-protein kinase TYK2(Homo sapiens (Human))
Pfizer Inc.

US Patent
LigandPNGBDBM305820((1s,3s)-3-(Cyanomethyl)-3-(4-(6-(1-methyl-1H-pyraz...)
Show SMILES Cn1cc(cn1)-c1cn2nccc2c(n1)-c1cnn(c1)[C@]1(CC#N)C[C@@H](C1)C#N
Show InChI InChI=1S/C20H17N9/c1-27-11-15(9-24-27)17-13-28-18(2-5-23-28)19(26-17)16-10-25-29(12-16)20(3-4-21)6-14(7-20)8-22/h2,5,9-14H,3,6-7H2,1H3/t14-,20+
Affinity DataIC50: 6nMAssay Description:Inhibition of recombinant human His-tagged TYK2 expressed in baculovirus infected Sf21 cells using 5FAM-KKSRGDYMTMQID as substrate in presence of ATP...More data for this Ligand-Target Pair
TargetNon-receptor tyrosine-protein kinase TYK2(Homo sapiens (Human))
Pfizer Inc.

US Patent
LigandPNGBDBM329989(US10463675, Example 72 | US10980815, Ex. No. 72 | ...)
Show SMILES CCNC(=O)c1ccc(Nc2ncc(F)c(n2)N2C[C@@H]3CC[C@H](C2)N3C(=O)C(F)(F)F)cc1C
Show InChI InChI=1S/C22H24F4N6O2/c1-3-27-19(33)16-7-4-13(8-12(16)2)29-21-28-9-17(23)18(30-21)31-10-14-5-6-15(11-31)32(14)20(34)22(24,25)26/h4,7-9,14-15H,3,5-6,10-11H2,1-2H3,(H,27,33)(H,28,29,30)/t14-,15+
Affinity DataIC50: 6nMAssay Description:Compounds were added to a 384-well plate. Reaction mixtures contained 10 mM HEPES, pH 7.4, 10 mM MgCl2, 0.01% BSA, 0.0005% Tween 20, 1 mM ATP and 1 M...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
TargetTyrosine-protein kinase JAK1(Homo sapiens (Human))
Pfizer Inc.

Curated by ChEMBL
LigandPNGBDBM50542404(CHEMBL4644578)
Show SMILES C[C@@H]1[C@@H]2CN(C[C@]12NC(=O)[C@@H]1C[C@H]1C#N)c1nc(Nc2cnn(CCO)c2)ncc1F
Show InChI InChI=1S/C20H23FN8O2/c1-11-15-9-28(10-20(11,15)27-18(31)14-4-12(14)5-22)17-16(21)7-23-19(26-17)25-13-6-24-29(8-13)2-3-30/h6-8,11-12,14-15,30H,2-4,9-10H2,1H3,(H,27,31)(H,23,25,26)/t11-,12+,14-,15+,20+/m1/s1
Affinity DataIC50: 6nMAssay Description:Inhibition of human recombinant JAK1 assessed as level of phosphorylation in presence of peptide substrate 5FAM-KKSRGDYMTMQUID and ATP by mobility sh...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
TargetNon-receptor tyrosine-protein kinase TYK2(Homo sapiens (Human))
Pfizer Inc.

US Patent
LigandPNGBDBM305820((1s,3s)-3-(Cyanomethyl)-3-(4-(6-(1-methyl-1H-pyraz...)
Show SMILES Cn1cc(cn1)-c1cn2nccc2c(n1)-c1cnn(c1)[C@]1(CC#N)C[C@@H](C1)C#N
Show InChI InChI=1S/C20H17N9/c1-27-11-15(9-24-27)17-13-28-18(2-5-23-28)19(26-17)16-10-25-29(12-16)20(3-4-21)6-14(7-20)8-22/h2,5,9-14H,3,6-7H2,1H3/t14-,20+
Affinity DataIC50: 6nMAssay Description:Compounds were added to a 384-well plate. Reaction mixtures contained 10 mM HEPES, pH 7.4, 10 mM MgCl2, 0.01% BSA, 0.0005% Tween 20, 1 mM ATP and 1 &...More data for this Ligand-Target Pair
TargetNon-receptor tyrosine-protein kinase TYK2(Homo sapiens (Human))
Pfizer Inc.

US Patent
LigandPNGBDBM305820((1s,3s)-3-(Cyanomethyl)-3-(4-(6-(1-methyl-1H-pyraz...)
Show SMILES Cn1cc(cn1)-c1cn2nccc2c(n1)-c1cnn(c1)[C@]1(CC#N)C[C@@H](C1)C#N
Show InChI InChI=1S/C20H17N9/c1-27-11-15(9-24-27)17-13-28-18(2-5-23-28)19(26-17)16-10-25-29(12-16)20(3-4-21)6-14(7-20)8-22/h2,5,9-14H,3,6-7H2,1H3/t14-,20+
Affinity DataIC50: 6nMAssay Description:Compounds were added to a 384-well plate. Reaction mixtures contained 10 mM HEPES, pH 7.4, 10 mM MgCl2, 0.01% BSA, 0.0005% Tween 20, 1 mM ATP and 1 &...More data for this Ligand-Target Pair
TargetNon-receptor tyrosine-protein kinase TYK2(Homo sapiens (Human))
Pfizer Inc.

US Patent
LigandPNGBDBM329989(US10463675, Example 72 | US10980815, Ex. No. 72 | ...)
Show SMILES CCNC(=O)c1ccc(Nc2ncc(F)c(n2)N2C[C@@H]3CC[C@H](C2)N3C(=O)C(F)(F)F)cc1C
Show InChI InChI=1S/C22H24F4N6O2/c1-3-27-19(33)16-7-4-13(8-12(16)2)29-21-28-9-17(23)18(30-21)31-10-14-5-6-15(11-31)32(14)20(34)22(24,25)26/h4,7-9,14-15H,3,5-6,10-11H2,1-2H3,(H,27,33)(H,28,29,30)/t14-,15+
Affinity DataIC50: 6nMAssay Description:Compounds were added to a 384-well plate. Reaction mixtures contained 10 mM HEPES, pH 7.4, 10 mM MgCl2, 0.01% BSA, 0.0005% Tween 20, 1 mM ATP and 1 &...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
TargetNon-receptor tyrosine-protein kinase TYK2(Homo sapiens (Human))
Pfizer Inc.

US Patent
LigandPNGBDBM329989(US10463675, Example 72 | US10980815, Ex. No. 72 | ...)
Show SMILES CCNC(=O)c1ccc(Nc2ncc(F)c(n2)N2C[C@@H]3CC[C@H](C2)N3C(=O)C(F)(F)F)cc1C
Show InChI InChI=1S/C22H24F4N6O2/c1-3-27-19(33)16-7-4-13(8-12(16)2)29-21-28-9-17(23)18(30-21)31-10-14-5-6-15(11-31)32(14)20(34)22(24,25)26/h4,7-9,14-15H,3,5-6,10-11H2,1-2H3,(H,27,33)(H,28,29,30)/t14-,15+
Affinity DataIC50: 6nMAssay Description:Compounds were added to a 384-well plate. Reaction mixtures contained 10 mM HEPES, pH 7.4, 10 mM MgCl2, 0.01% BSA, 0.0005% Tween 20, 1 mM ATP and 1 &...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
TargetNon-receptor tyrosine-protein kinase TYK2(Homo sapiens (Human))
Pfizer Inc.

US Patent
LigandPNGBDBM305820((1s,3s)-3-(Cyanomethyl)-3-(4-(6-(1-methyl-1H-pyraz...)
Show SMILES Cn1cc(cn1)-c1cn2nccc2c(n1)-c1cnn(c1)[C@]1(CC#N)C[C@@H](C1)C#N
Show InChI InChI=1S/C20H17N9/c1-27-11-15(9-24-27)17-13-28-18(2-5-23-28)19(26-17)16-10-25-29(12-16)20(3-4-21)6-14(7-20)8-22/h2,5,9-14H,3,6-7H2,1H3/t14-,20+
Affinity DataIC50: 6nMAssay Description:Compounds were added to a 384-well plate. Reaction mixtures contained 10 mM HEPES, pH 7.4, 10 mM MgCl2, 0.01% BSA, 0.0005% Tween 20, 1 mM ATP and 1 &...More data for this Ligand-Target Pair
TargetNon-receptor tyrosine-protein kinase TYK2(Homo sapiens (Human))
Pfizer Inc.

US Patent
LigandPNGBDBM329989(US10463675, Example 72 | US10980815, Ex. No. 72 | ...)
Show SMILES CCNC(=O)c1ccc(Nc2ncc(F)c(n2)N2C[C@@H]3CC[C@H](C2)N3C(=O)C(F)(F)F)cc1C
Show InChI InChI=1S/C22H24F4N6O2/c1-3-27-19(33)16-7-4-13(8-12(16)2)29-21-28-9-17(23)18(30-21)31-10-14-5-6-15(11-31)32(14)20(34)22(24,25)26/h4,7-9,14-15H,3,5-6,10-11H2,1-2H3,(H,27,33)(H,28,29,30)/t14-,15+
Affinity DataIC50: 6nMAssay Description:Compounds were added to a 384-well plate. Reaction mixtures contained 10 mM HEPES, pH 7.4, 10 mM MgCl2, 0.01% BSA, 0.0005% Tween 20, 1 mM ATP and 1 &...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
TargetNon-receptor tyrosine-protein kinase TYK2(Homo sapiens (Human))
Pfizer Inc.

US Patent
LigandPNGBDBM305808(2,2′-(3-(4-(6-(1-Methyl-1H-pyrazol-4-yl)pyra...)
Show SMILES Cn1cc(cn1)-c1cn2nccc2c(n1)-c1cnn(c1)C1(CC#N)CN(CC#N)C1
Show InChI InChI=1S/C20H18N10/c1-27-10-15(8-24-27)17-12-29-18(2-6-23-29)19(26-17)16-9-25-30(11-16)20(3-4-21)13-28(14-20)7-5-22/h2,6,8-12H,3,7,13-14H2,1H3
Affinity DataIC50: 7nMAssay Description:Compounds were added to a 384-well plate. Reaction mixtures contained 10 mM HEPES, pH 7.4, 10 mM MgCl2, 0.01% BSA, 0.0005% Tween 20, 1 mM ATP and 1 &...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
TargetNon-receptor tyrosine-protein kinase TYK2(Homo sapiens (Human))
Pfizer Inc.

US Patent
LigandPNGBDBM305808(2,2′-(3-(4-(6-(1-Methyl-1H-pyrazol-4-yl)pyra...)
Show SMILES Cn1cc(cn1)-c1cn2nccc2c(n1)-c1cnn(c1)C1(CC#N)CN(CC#N)C1
Show InChI InChI=1S/C20H18N10/c1-27-10-15(8-24-27)17-12-29-18(2-6-23-29)19(26-17)16-9-25-30(11-16)20(3-4-21)13-28(14-20)7-5-22/h2,6,8-12H,3,7,13-14H2,1H3
Affinity DataIC50: 7nMAssay Description:Compounds were added to a 384-well plate. Reaction mixtures contained 10 mM HEPES, pH 7.4, 10 mM MgCl2, 0.01% BSA, 0.0005% Tween 20, 1 mM ATP and 1 &...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
TargetNon-receptor tyrosine-protein kinase TYK2(Homo sapiens (Human))
Pfizer Inc.

US Patent
LigandPNGBDBM538703(US11254668, Example 43 | US11254668, Example 44)
Show SMILES Cc1cc(n[nH]1)-c1cc2ncccc2c(n1)-c1ccn(n1)C1(CC#N)CC(C1)C#N
Show InChI InChI=1S/C22H18N8/c1-14-9-20(28-27-14)19-10-18-16(3-2-7-25-18)21(26-19)17-4-8-30(29-17)22(5-6-23)11-15(12-22)13-24/h2-4,7-10,15H,5,11-12H2,1H3,(H,27,28)
Affinity DataIC50: 7nMAssay Description:Compounds were added to a 384-well plate. Reaction mixtures contained 10 mM HEPES, pH 7.4, 10 mM MgCl2, 0.01% BSA, 0.0005% Tween 20, 1 mM ATP and 1 &...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
TargetNon-receptor tyrosine-protein kinase TYK2(Homo sapiens (Human))
Pfizer Inc.

US Patent
LigandPNGBDBM538708(US11254668, Example 48 | US11254668, Example 49)
Show SMILES OCc1cc(n[nH]1)-c1cc2ncccc2c(n1)-c1ccn(n1)C1(CC#N)CC(C1)C#N
Show InChI InChI=1S/C22H18N8O/c23-5-4-22(10-14(11-22)12-24)30-7-3-17(29-30)21-16-2-1-6-25-18(16)9-19(26-21)20-8-15(13-31)27-28-20/h1-3,6-9,14,31H,4,10-11,13H2,(H,27,28)
Affinity DataIC50: 7nMAssay Description:Compounds were added to a 384-well plate. Reaction mixtures contained 10 mM HEPES, pH 7.4, 10 mM MgCl2, 0.01% BSA, 0.0005% Tween 20, 1 mM ATP and 1 &...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
TargetNon-receptor tyrosine-protein kinase TYK2(Homo sapiens (Human))
Pfizer Inc.

US Patent
LigandPNGBDBM539040(US11254668, Example 383 | US11254668, Example 384)
Show SMILES COc1nc(ccc1N)-c1cc(-c2cnn(n2)C2(CC#N)CC(C2)C#N)c2cccnc2c1
Show InChI InChI=1S/C24H20N8O/c1-33-23-19(27)4-5-20(30-23)16-9-18(17-3-2-8-28-21(17)10-16)22-14-29-32(31-22)24(6-7-25)11-15(12-24)13-26/h2-5,8-10,14-15H,6,11-12,27H2,1H3
Affinity DataIC50: 7nMAssay Description:Compounds were added to a 384-well plate. Reaction mixtures contained 10 mM HEPES, pH 7.4, 10 mM MgCl2, 0.01% BSA, 0.0005% Tween 20, 1 mM ATP and 1 &...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
TargetNon-receptor tyrosine-protein kinase TYK2(Homo sapiens (Human))
Pfizer Inc.

US Patent
LigandPNGBDBM539006(US11254668, Example 349 | US11254668, Example 350)
Show SMILES NC(=O)c1cccc(n1)-c1cc(-c2cnn(n2)C2(CC#N)CC(C2)C#N)c2cccnc2c1
Show InChI InChI=1S/C24H18N8O/c25-7-6-24(11-15(12-24)13-26)32-29-14-22(31-32)18-9-16(10-21-17(18)3-2-8-28-21)19-4-1-5-20(30-19)23(27)33/h1-5,8-10,14-15H,6,11-12H2,(H2,27,33)
Affinity DataIC50: 7nMAssay Description:Compounds were added to a 384-well plate. Reaction mixtures contained 10 mM HEPES, pH 7.4, 10 mM MgCl2, 0.01% BSA, 0.0005% Tween 20, 1 mM ATP and 1 &...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
TargetNon-receptor tyrosine-protein kinase TYK2(Homo sapiens (Human))
Pfizer Inc.

US Patent
LigandPNGBDBM538857(US11254668, Example 198 | US11254668, Example 199)
Show SMILES Nc1cc(ccn1)-c1cc2ncccc2c(n1)-c1ccn(n1)C1(CC#N)CC(C1)C#N
Show InChI InChI=1S/C23H18N8/c24-6-5-23(12-15(13-23)14-25)31-9-4-18(30-31)22-17-2-1-7-27-20(17)11-19(29-22)16-3-8-28-21(26)10-16/h1-4,7-11,15H,5,12-13H2,(H2,26,28)
Affinity DataIC50: 7nMAssay Description:Compounds were added to a 384-well plate. Reaction mixtures contained 10 mM HEPES, pH 7.4, 10 mM MgCl2, 0.01% BSA, 0.0005% Tween 20, 1 mM ATP and 1 &...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
TargetNon-receptor tyrosine-protein kinase TYK2(Homo sapiens (Human))
Pfizer Inc.

US Patent
LigandPNGBDBM538818(US11254668, Example 159)
Show SMILES CS(=O)(=O)N1CC(CC#N)(C1)n1ccc(n1)-c1nc(cc2ncccc12)-c1c[nH]c2ncccc12
Show InChI InChI=1S/C24H20N8O2S/c1-35(33,34)31-14-24(15-31,7-8-25)32-11-6-19(30-32)22-17-5-3-9-26-20(17)12-21(29-22)18-13-28-23-16(18)4-2-10-27-23/h2-6,9-13H,7,14-15H2,1H3,(H,27,28)
Affinity DataIC50: 7nMAssay Description:Compounds were added to a 384-well plate. Reaction mixtures contained 10 mM HEPES, pH 7.4, 10 mM MgCl2, 0.01% BSA, 0.0005% Tween 20, 1 mM ATP and 1 &...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
TargetNon-receptor tyrosine-protein kinase TYK2(Homo sapiens (Human))
Pfizer Inc.

US Patent
LigandPNGBDBM538963(US11254668, Example 306 | US11254668, Example 307)
Show SMILES Nc1cc(n[nH]1)-c1cc(-c2cnn(n2)C2(CC#N)CC(C2)C#N)c2cccnc2c1
Show InChI InChI=1S/C21H17N9/c22-4-3-21(9-13(10-21)11-23)30-26-12-19(29-30)16-6-14(17-8-20(24)28-27-17)7-18-15(16)2-1-5-25-18/h1-2,5-8,12-13H,3,9-10H2,(H3,24,27,28)
Affinity DataIC50: 7nMAssay Description:Compounds were added to a 384-well plate. Reaction mixtures contained 10 mM HEPES, pH 7.4, 10 mM MgCl2, 0.01% BSA, 0.0005% Tween 20, 1 mM ATP and 1 &...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
TargetNon-receptor tyrosine-protein kinase TYK2(Homo sapiens (Human))
Pfizer Inc.

US Patent
LigandPNGBDBM538761(US11254668, Example 102 | US11254668, Example 103)
Show SMILES Cn1cc(cn1)-c1cc2ncccc2c(n1)-c1ccn(n1)C1(CC#N)CC(C1)C#N
Show InChI InChI=1S/C22H18N8/c1-29-14-16(13-26-29)19-9-20-17(3-2-7-25-20)21(27-19)18-4-8-30(28-18)22(5-6-23)10-15(11-22)12-24/h2-4,7-9,13-15H,5,10-11H2,1H3
Affinity DataIC50: 7nMAssay Description:Compounds were added to a 384-well plate. Reaction mixtures contained 10 mM HEPES, pH 7.4, 10 mM MgCl2, 0.01% BSA, 0.0005% Tween 20, 1 mM ATP and 1 &...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
TargetNon-receptor tyrosine-protein kinase TYK2(Homo sapiens (Human))
Pfizer Inc.

US Patent
LigandPNGBDBM538736(US11254668, Example 76 | US11254668, Example 77)
Show SMILES N#CCC1(CC(C1)C#N)n1ccc(n1)-c1nc(cc2ncccc12)-c1cn[nH]c1
Show InChI InChI=1S/C21H16N8/c22-5-4-21(9-14(10-21)11-23)29-7-3-17(28-29)20-16-2-1-6-24-19(16)8-18(27-20)15-12-25-26-13-15/h1-3,6-8,12-14H,4,9-10H2,(H,25,26)
Affinity DataIC50: 7nMAssay Description:Compounds were added to a 384-well plate. Reaction mixtures contained 10 mM HEPES, pH 7.4, 10 mM MgCl2, 0.01% BSA, 0.0005% Tween 20, 1 mM ATP and 1 &...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
TargetNon-receptor tyrosine-protein kinase TYK2(Homo sapiens (Human))
Pfizer Inc.

US Patent
LigandPNGBDBM538752(US11254668, Example 93)
Show SMILES CS(=O)(=O)N1CC(CC#N)(C1)n1ccc(n1)-c1nc(cc2ncccc12)-c1c[nH]nc1N
Show InChI InChI=1S/C20H19N9O2S/c1-32(30,31)28-11-20(12-28,5-6-21)29-8-4-15(27-29)18-13-3-2-7-23-16(13)9-17(25-18)14-10-24-26-19(14)22/h2-4,7-10H,5,11-12H2,1H3,(H3,22,24,26)
Affinity DataIC50: 7nMAssay Description:Compounds were added to a 384-well plate. Reaction mixtures contained 10 mM HEPES, pH 7.4, 10 mM MgCl2, 0.01% BSA, 0.0005% Tween 20, 1 mM ATP and 1 &...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
TargetNon-receptor tyrosine-protein kinase TYK2(Homo sapiens (Human))
Pfizer Inc.

US Patent
LigandPNGBDBM538725(US11254668, Example 65 | US11254668, Example 66)
Show SMILES Cn1nc(cc1N)-c1cc2ncccc2c(n1)-c1ccn(n1)C1(CC#N)CC(C1)C#N
Show InChI InChI=1S/C22H19N9/c1-30-20(25)10-19(28-30)18-9-17-15(3-2-7-26-17)21(27-18)16-4-8-31(29-16)22(5-6-23)11-14(12-22)13-24/h2-4,7-10,14H,5,11-12,25H2,1H3
Affinity DataIC50: 7nMAssay Description:Compounds were added to a 384-well plate. Reaction mixtures contained 10 mM HEPES, pH 7.4, 10 mM MgCl2, 0.01% BSA, 0.0005% Tween 20, 1 mM ATP and 1 &...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
TargetTyrosine-protein kinase JAK1(Homo sapiens (Human))
Pfizer Inc.

Curated by ChEMBL
LigandPNGBDBM419640(US10463675, Example 83 | US10980815, Ex. No. 83 | ...)
Show SMILES Cn1cc(Nc2nccc(n2)N2C[C@@H]3CC[C@H](C2)N3C2(CC#N)CN(C2)S(C)(=O)=O)cn1
Show InChI InChI=1S/C20H27N9O2S/c1-26-10-15(9-23-26)24-19-22-8-5-18(25-19)27-11-16-3-4-17(12-27)29(16)20(6-7-21)13-28(14-20)32(2,30)31/h5,8-10,16-17H,3-4,6,11-14H2,1-2H3,(H,22,24,25)/t16-,17+
Affinity DataIC50: 7nMAssay Description:Compounds were added to a 384-well plate. Reaction mixtures contained 10 mM HEPES, pH 7.4, 10 mM MgCl2, 0.01% BSA, 0.0005% Tween 20, 1 mM ATP and 1 M...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
TargetNon-receptor tyrosine-protein kinase TYK2(Homo sapiens (Human))
Pfizer Inc.

US Patent
LigandPNGBDBM305808(2,2′-(3-(4-(6-(1-Methyl-1H-pyrazol-4-yl)pyra...)
Show SMILES Cn1cc(cn1)-c1cn2nccc2c(n1)-c1cnn(c1)C1(CC#N)CN(CC#N)C1
Show InChI InChI=1S/C20H18N10/c1-27-10-15(8-24-27)17-12-29-18(2-6-23-29)19(26-17)16-9-25-30(11-16)20(3-4-21)13-28(14-20)7-5-22/h2,6,8-12H,3,7,13-14H2,1H3
Affinity DataIC50: 7nMAssay Description:Inhibition of recombinant human His-tagged TYK2 expressed in baculovirus infected Sf21 cells using 5FAM-KKSRGDYMTMQID as substrate in presence of ATP...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
TargetTyrosine-protein kinase JAK1(Homo sapiens (Human))
Pfizer Inc.

Curated by ChEMBL
LigandPNGBDBM419640(US10463675, Example 83 | US10980815, Ex. No. 83 | ...)
Show SMILES Cn1cc(Nc2nccc(n2)N2C[C@@H]3CC[C@H](C2)N3C2(CC#N)CN(C2)S(C)(=O)=O)cn1
Show InChI InChI=1S/C20H27N9O2S/c1-26-10-15(9-23-26)24-19-22-8-5-18(25-19)27-11-16-3-4-17(12-27)29(16)20(6-7-21)13-28(14-20)32(2,30)31/h5,8-10,16-17H,3-4,6,11-14H2,1-2H3,(H,22,24,25)/t16-,17+
Affinity DataIC50: 7nMAssay Description:Compounds were added to a 384-well plate. Reaction mixtures contained 10 mM HEPES, pH 7.4, 10 mM MgCl2, 0.01% BSA, 0.0005% Tween 20, 1 mM ATP and 1 &...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
TargetNon-receptor tyrosine-protein kinase TYK2(Homo sapiens (Human))
Pfizer Inc.

US Patent
LigandPNGBDBM305831(2-((1r,3s)-1-(4-(6-(3-Amino-1H-pyrazol-5-yl)pyrazo...)
Show SMILES CO[C@H]1C[C@@](CC#N)(C1)n1cc(cn1)-c1nc(cn2nccc12)-c1cc(N)[nH]n1
Affinity DataIC50: 7nMAssay Description:Compounds were added to a 384-well plate. Reaction mixtures contained 10 mM HEPES, pH 7.4, 10 mM MgCl2, 0.01% BSA, 0.0005% Tween 20, 1 mM ATP and 1 &...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
TargetNon-receptor tyrosine-protein kinase TYK2(Homo sapiens (Human))
Pfizer Inc.

US Patent
LigandPNGBDBM305808(2,2′-(3-(4-(6-(1-Methyl-1H-pyrazol-4-yl)pyra...)
Show SMILES Cn1cc(cn1)-c1cn2nccc2c(n1)-c1cnn(c1)C1(CC#N)CN(CC#N)C1
Show InChI InChI=1S/C20H18N10/c1-27-10-15(8-24-27)17-12-29-18(2-6-23-29)19(26-17)16-9-25-30(11-16)20(3-4-21)13-28(14-20)7-5-22/h2,6,8-12H,3,7,13-14H2,1H3
Affinity DataIC50: 7nMAssay Description:Compounds were added to a 384-well plate. Reaction mixtures contained 10 mM HEPES, pH 7.4, 10 mM MgCl2, 0.01% BSA, 0.0005% Tween 20, 1 mM ATP and 1 &...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
TargetTyrosine-protein kinase JAK1(Homo sapiens (Human))
Pfizer Inc.

Curated by ChEMBL
LigandPNGBDBM419640(US10463675, Example 83 | US10980815, Ex. No. 83 | ...)
Show SMILES Cn1cc(Nc2nccc(n2)N2C[C@@H]3CC[C@H](C2)N3C2(CC#N)CN(C2)S(C)(=O)=O)cn1
Show InChI InChI=1S/C20H27N9O2S/c1-26-10-15(9-23-26)24-19-22-8-5-18(25-19)27-11-16-3-4-17(12-27)29(16)20(6-7-21)13-28(14-20)32(2,30)31/h5,8-10,16-17H,3-4,6,11-14H2,1-2H3,(H,22,24,25)/t16-,17+
Affinity DataIC50: 7nMAssay Description:Compounds were added to a 384-well plate. Reaction mixtures contained 10 mM HEPES, pH 7.4, 10 mM MgCl2, 0.01% BSA, 0.0005% Tween 20, 1 mM ATP and 1 &...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
TargetTyrosine-protein kinase JAK1(Homo sapiens (Human))
Pfizer Inc.

Curated by ChEMBL
LigandPNGBDBM330000(US9663526, Example 83)
Show SMILES Cn1cc(Nc2nccc(n2)N2C[C@@H]3CC[C@H](C2)N3C2(C[N+]#[C-])CN(C2)S(C)(=O)=O)cn1
Show InChI InChI=1S/C20H27N9O2S/c1-21-12-20(13-28(14-20)32(3,30)31)29-16-4-5-17(29)11-27(10-16)18-6-7-22-19(25-18)24-15-8-23-26(2)9-15/h6-9,16-17H,4-5,10-14H2,2-3H3,(H,22,24,25)/t16-,17+
Ligand InfoPC cidPC sid
TargetNon-receptor tyrosine-protein kinase TYK2(Homo sapiens (Human))
Pfizer Inc.

US Patent
LigandPNGBDBM305831(2-((1r,3s)-1-(4-(6-(3-Amino-1H-pyrazol-5-yl)pyrazo...)
Show SMILES CO[C@H]1C[C@@](CC#N)(C1)n1cc(cn1)-c1nc(cn2nccc12)-c1cc(N)[nH]n1
Affinity DataIC50: 7nMAssay Description:Compounds were added to a 384-well plate. Reaction mixtures contained 10 mM HEPES, pH 7.4, 10 mM MgCl2, 0.01% BSA, 0.0005% Tween 20, 1 mM ATP and 1 &...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
TargetNon-receptor tyrosine-protein kinase TYK2(Homo sapiens (Human))
Pfizer Inc.

US Patent
LigandPNGBDBM305808(2,2′-(3-(4-(6-(1-Methyl-1H-pyrazol-4-yl)pyra...)
Show SMILES Cn1cc(cn1)-c1cn2nccc2c(n1)-c1cnn(c1)C1(CC#N)CN(CC#N)C1
Show InChI InChI=1S/C20H18N10/c1-27-10-15(8-24-27)17-12-29-18(2-6-23-29)19(26-17)16-9-25-30(11-16)20(3-4-21)13-28(14-20)7-5-22/h2,6,8-12H,3,7,13-14H2,1H3
Affinity DataIC50: 7nMAssay Description:Compounds were added to a 384-well plate. Reaction mixtures contained 10 mM HEPES, pH 7.4, 10 mM MgCl2, 0.01% BSA, 0.0005% Tween 20, 1 mM ATP and 1 &...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
TargetNon-receptor tyrosine-protein kinase TYK2(Homo sapiens (Human))
Pfizer Inc.

US Patent
LigandPNGBDBM305831(2-((1r,3s)-1-(4-(6-(3-Amino-1H-pyrazol-5-yl)pyrazo...)
Show SMILES CO[C@H]1C[C@@](CC#N)(C1)n1cc(cn1)-c1nc(cn2nccc12)-c1cc(N)[nH]n1
Affinity DataIC50: 7nMAssay Description:Compounds were added to a 384-well plate. Reaction mixtures contained 10 mM HEPES, pH 7.4, 10 mM MgCl2, 0.01% BSA, 0.0005% Tween 20, 1 mM ATP and 1 &...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
TargetNon-receptor tyrosine-protein kinase TYK2(Homo sapiens (Human))
Pfizer Inc.

US Patent
LigandPNGBDBM305831(2-((1r,3s)-1-(4-(6-(3-Amino-1H-pyrazol-5-yl)pyrazo...)
Show SMILES CO[C@H]1C[C@@](CC#N)(C1)n1cc(cn1)-c1nc(cn2nccc12)-c1cc(N)[nH]n1
Affinity DataIC50: 7nMAssay Description:Compounds were added to a 384-well plate. Reaction mixtures contained 10 mM HEPES, pH 7.4, 10 mM MgCl2, 0.01% BSA, 0.0005% Tween 20, 1 mM ATP and 1 &...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
TargetNon-receptor tyrosine-protein kinase TYK2(Homo sapiens (Human))
Pfizer Inc.

US Patent
LigandPNGBDBM305810(2-(1-(Cyclopropylsulfonyl)-3-(4-(6-(1-methyl-1H-py...)
Show SMILES Cn1cc(cn1)-c1cn2nccc2c(n1)-c1cnn(c1)C1(CC#N)CN(C1)S(=O)(=O)C1CC1
Show InChI InChI=1S/C21H21N9O2S/c1-27-10-15(8-24-27)18-12-29-19(4-7-23-29)20(26-18)16-9-25-30(11-16)21(5-6-22)13-28(14-21)33(31,32)17-2-3-17/h4,7-12,17H,2-3,5,13-14H2,1H3
Affinity DataIC50: 8nMAssay Description:Compounds were added to a 384-well plate. Reaction mixtures contained 10 mM HEPES, pH 7.4, 10 mM MgCl2, 0.01% BSA, 0.0005% Tween 20, 1 mM ATP and 1 &...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
TargetTyrosine-protein kinase JAK2(Homo sapiens (Human))
Pfizer Inc.

US Patent
LigandPNGBDBM305820((1s,3s)-3-(Cyanomethyl)-3-(4-(6-(1-methyl-1H-pyraz...)
Show SMILES Cn1cc(cn1)-c1cn2nccc2c(n1)-c1cnn(c1)[C@]1(CC#N)C[C@@H](C1)C#N
Show InChI InChI=1S/C20H17N9/c1-27-11-15(9-24-27)17-13-28-18(2-5-23-28)19(26-17)16-10-25-29(12-16)20(3-4-21)6-14(7-20)8-22/h2,5,9-14H,3,6-7H2,1H3/t14-,20+
Affinity DataIC50: 8nMAssay Description:Compounds were added to a 384-well plate. Reaction mixtures contained 10 mM HEPES, pH 7.4, 10 mM MgCl2, 0.01% BSA, 0.0005% Tween 20, 1 mM ATP and 1 &...More data for this Ligand-Target Pair
TargetTyrosine-protein kinase JAK2(Homo sapiens (Human))
Pfizer Inc.

US Patent
LigandPNGBDBM305820((1s,3s)-3-(Cyanomethyl)-3-(4-(6-(1-methyl-1H-pyraz...)
Show SMILES Cn1cc(cn1)-c1cn2nccc2c(n1)-c1cnn(c1)[C@]1(CC#N)C[C@@H](C1)C#N
Show InChI InChI=1S/C20H17N9/c1-27-11-15(9-24-27)17-13-28-18(2-5-23-28)19(26-17)16-10-25-29(12-16)20(3-4-21)6-14(7-20)8-22/h2,5,9-14H,3,6-7H2,1H3/t14-,20+
Affinity DataIC50: 8nMAssay Description:Compounds were added to a 384-well plate. Reaction mixtures contained 10 mM HEPES, pH 7.4, 10 mM MgCl2, 0.01% BSA, 0.0005% Tween 20, 1 mM ATP and 1 &...More data for this Ligand-Target Pair
TargetNon-receptor tyrosine-protein kinase TYK2(Homo sapiens (Human))
Pfizer Inc.

US Patent
LigandPNGBDBM329971(US10463675, Example 54 | US10980815, Ex. No. 54 | ...)
Show SMILES CNC(=O)c1ncc(Nc2nccc(n2)N2C[C@@H]3CC[C@H](C2)N3CC2(C)COC2)cc1C
Show InChI InChI=1S/C23H31N7O2/c1-15-8-16(9-26-20(15)21(31)24-3)27-22-25-7-6-19(28-22)29-10-17-4-5-18(11-29)30(17)12-23(2)13-32-14-23/h6-9,17-18H,4-5,10-14H2,1-3H3,(H,24,31)(H,25,27,28)/t17-,18+
Affinity DataIC50: 8nMAssay Description:Compounds were added to a 384-well plate. Reaction mixtures contained 10 mM HEPES, pH 7.4, 10 mM MgCl2, 0.01% BSA, 0.0005% Tween 20, 1 mM ATP and 1 M...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
Displayed 1 to 50 (of 4903 total ) | Next | Last >>
Jump to: